Pharmaceutical
Pharmaceutical
Pharmaceutical matters are high-stakes, data-heavy, and unforgiving. We help pharmaceutical companies and their counsel manage regulatory investigations, IP disputes, product liability litigation, and compliance reviews with structured, defensible discovery built for scientific and commercial complexity.
Talk to an Expert
What Pharmaceutical Legal Teams
Achieve with Lineal
-
review volume reduced in high-stakes pharmaceutical IP litigation
through structured data culling and AI-driven workflows -
additional reduction achieved post-processing using Amplify™ suppression logic and entity intelligence
-
annual discovery spend transformed into a strategic legal advantage across pharmaceutical portfolios annually
Key Industry Challenges
The Practice Has Evolved. Has Your Data?
-
Tight timelines, tighter budgets
-
Need for institutional memory, not just document recall
-
Diverse data formats (chats, hyperlinked documents, structured data, images)
-
Pressure to deliver strategic value — not just results
HOW WE HELP PHARMACEUTICAL
Smarter Pharmaceutical Practice
Starts with Smarter Data
We partner with pharmaceutical companies and their counsel to engineer discovery environments
that scale across portfolios, preserve scientific nuance, and withstand regulatory scrutiny.
-
Challenge
You’re reinventing workflows on every pharmaceutical matter.
Outcome:
Amplify™ Suite of Tools captures review logic, entity patterns, privilege calls, and suppression decisions across matters. Your tenth pharma case does not start from zero. Institutional intelligence compounds, reducing rework and accelerating time to defensible insight.
-
Challenge
Too many reviewers. Not enough strategic focus.
Outcome:
Amplify-driven early intelligence reduces population before human review begins — through structured data filtering, privilege actor detection, chat reconstruction, and suppression of low-value communications. Review teams focus on scientific and strategic issues, not noise.
-
Challenge
Limited visibility into portfolio-wide cost and performance.
Outcome:
Command Center provides real-time dashboards tracking matter velocity, custodian activity, document volumes, and financial exposure. Legal leadership sees risk and spend before they escalate — not after invoices arrive.
-
Challenge
You need to scale matters — not internal headcount.
Outcome:
Lineal’s global managed review and subject-matter experts support surge capacity, multilingual review, and scientific document handling with predictable pricing models. Scale without staffing volatility.
Recognized for
Excellence and
Innovation
Case Studies
-
Read the Case Study
Industry: Corporate
Accelerating Multi-Jurisdiction Competition Audit Review
Challenge:
Seven countries. Nine languages. 8.6 million documents. A competition law audit that traditional review could not finish in time.
Outcome:
Audit completed on time. Out of 8.6 million documents loaded, only 87,000 required human review. Defensible, regulator-ready results across every jurisdiction.
-
8.6M
Documents loaded across seven countries and nine languages.
-
~87K
Documents actually reviewed. A fraction of the total population.
-
7 Countries, 9 Languages
Consistent, defensible relevance determinations across every jurisdiction.
-
-
Read the Case Study
Industry: Financial services, Investigations
Anti-Money Laundering Investigation for a Global Bank
Challenge:
A major global bank faced an AML investigation requiring review of 12+ million documents under a strict 3-month deadline. High-risk data patterns needed precise identification, and the cost of a traditional review approach was not an option.
Outcome:
Lineal reduced review volume by 97%. Fewer than 3% of documents required manual assessment. Deadline met, defensible results delivered, fixed fee.
-
97%
Review volume reduced with less than 3% of documents touched by human reviewers.
-
12M+
Documents processed using AI-powered categorization and clustering.
-
3 Months
Regulatory deadline met with no delays.
-
-
Read the Case Study
Industry: Pharmaceutical
Defensible Scope Reduction in High-Stakes Pharmaceutical IP Litigation
Challenge:
A Fortune 100 pharmaceutical company needed to review a large, complex document population under litigation pressure. Traditional first-pass review models would have been too slow, too expensive, and too inconsistent.
Outcome:
Lineal eliminated first-pass review entirely. Over 95% of the document population was reduced before a human reviewer saw a single document. Full defensibility maintained.
-
95%+
Review volume reduced before human review began.
-
70%
Additional reduction post-Amplify™ through AI-assisted relevance assessment.
-
100%
Defensible decisions with documented, SME-governed coding logic.
-
-
Read the Case Study
Industry: Law Firms
Document Review in Criminal Investigation
Challenge:
52,795 FBI-provided documents for the Andrade criminal investigation. A status conference deadline. The case team needed to move beyond linear review and organize the full universe by concept.
Outcome:
Amplify™ tools covered 98% of the document universe. Textual Near Duplicate Identification handled 68%. Lineal Images addressed the remaining 30% of image file types. Deadline met.
-
52,795
FBI-provided documents reviewed for the status conference.
-
68%
Document universe addressed by Textual Near Duplicate Identification.
-
30%
Image file types addressed by Lineal Images classification.
-
-
Read the Case Study
Industry: Law Firms
Efficient Data Management for a Complex Legal Dispute
Challenge:
3 million documents from 140+ custodians, transferred from a previous vendor. The data needed to be verified for completeness, then the legal team needed a fast path to the evidence that mattered.
Outcome:
The full Amplify™ Suite of Tools cut through the volume. Email threading, BotDetector, PrivFinder, Snippets, and Lineal Images each took a layer off until the legal team had a clear path to relevant evidence.
-
3M
Documents processed from 140+ custodians.
-
641,098
Documents reduced through email threading alone.
-
731,681
Documents ring-fenced for targeted privilege review with PrivFinder.
-
-
Read the Case Study
Industry: Corporate
High-Volume Data Breach Response for a Fortune 20 Retailer
Challenge:
A major ransomware incident. 22 million structured records with PII and PHI exposed. Three weeks to figure out who was affected and meet federal and state notification requirements.
Outcome:
Lineal delivered a precise breach assessment within the deadline. Defensible, regulator-ready output. Reduced class-action exposure through accurate identification of affected individuals.
-
22M+
Structured records processed containing PII and PHI.
-
3 Weeks
Regulatory notification deadline met with defensible output.
-
0
Large-scale manual review required. Automated detection throughout.
-
Why Lineal for
Pharmaceutical Operations
Lineal has earned the Relativity Life Sciences & Pharmaceutical Industry Competency, demonstrating validated expertise in applying RelativityOne best practices to complex pharmaceutical matters.
This is not general discovery experience. It is certified, industry-aligned execution.
-
Data Expertise Built for Pharmaceutical Operations
We understand scientific data structures, clinical workflows, regulatory documentation, and commercial communication patterns. Structured and unstructured data are treated as integrated evidence — not separate streams.
-
Intelligence That Compounds Across Matters
Amplify™ Suite of Tools preserves decision logic, entity intelligence, and review patterns. Your pharmaceutical portfolio becomes more efficient over time — not more fragmented.
-
Regulatory-Ready Defensibility
Every workflow is aligned to auditability standards and cross-border data governance. Structured documentation, preserved chain-of-custody, and explainable AI workflows withstand regulatory scrutiny.
-
Speed Without Sacrificing Scientific Context
Pharma timelines are urgent. But nuance matters. We engineer workflows that accelerate review while preserving scientific, clinical, and commercial context critical to outcome.
-
Partnership That Reduces Operational Burden
We embed into your operating model — not around it. We finish what we start, eliminate friction, and make pharmaceutical legal operations measurably easier to manage.
Resources & Insights
Explore more-
Unlocking AI in Legal Workflows
1Over this series we’ve seen that AI is not one thing but a decades-long layering of ideas. In the first post, we looked back — from handcrafted rules to modern large language models — and saw that new breakthroughs don’t erase the value of older methods. In the second, we went from theory to practice: exploring how […]
-
Faster, Smarter Investigations for APAC Legal Teams: Transforming Review with Amplify™
Rethinking Investigations in Asia Pacific Across the Asia Pacific region, legal and compliance teams are under increasing pressure. Regulatory scrutiny is intensifying. Internal investigations are growing more complex. And with diverse data privacy laws—from Singapore’s PDPA to China’s PIPL—teams must respond quickly while remaining compliant across jurisdictions. Yet many investigations still rely on outdated review […]
-
Legalweek Recap: AI Is Table Stakes. Effectiveness Is the Differentiator
AI is now standard in eDiscovery. Lineal breaks down what actually separates effective AI from a polished demo: workflow, environment, and accountability.
Ready to Redefine
Legal Data?
Tell us your challenge, we’ll help you solve it faster, smarter, and defensibly.
Thank you for reaching out.
A member of our team will be in touch shortly.